Contamination of Bacillus Species Sepsis.

NCT ID: NCT03377530

Last Updated: 2019-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

11 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-01

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bacillus species are ubiquitous gram-positive spore-forming organisms. They rarely cause disease in the immunocompetent and are more frequently isolated as a culture contaminant. However, Bacillus Species can cause severe systemic infections in immunocompromised patients including preterm infants.

The purpose of this study is to identify the risk factors of these infections.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non-anthrax Bacillus Species bacteria can be responsible for food poisoning and local infections. Rarely, they lead to severe infections like blood stream infections and meningitis especially in immunocompromised patients like preterm infants.

Bacillus Cereus is the most common members of the genus Bacillus. Only few reports studied these systemic infections in premature neonates. In order to identify the risk factors for severe Bacillus Species infections, we studied retrospectively eleven cases of these infections in our NICU and reviewed series and report cases in literature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bacillus Cereus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Premature neonates infected with bacillus Species

The investigators studied retrospectively eleven cases of these infections in our NICU and reviewed series and report cases in literature.

Ways to prevent these infections.

Intervention Type DIAGNOSTIC_TEST

The purpose of this database is to describe the pathogenicity of this germ, the incriminated modes of contamination.

The collaborators studied the factors of poor prognosis and propose ways to prevent these infections.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ways to prevent these infections.

The purpose of this database is to describe the pathogenicity of this germ, the incriminated modes of contamination.

The collaborators studied the factors of poor prognosis and propose ways to prevent these infections.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cases of Bacillus Species sepsis
* cases of Bacillus species meningitis
* with significant change in clinical status
* Bacillus Species is the only organism isolated

Exclusion Criteria

* Bacillus Species isolated with other organisms and Bacillus Species without clinical change were considered to be contaminants
Maximum Eligible Age

28 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital NOVO

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed Amine YANGUI

Role: PRINCIPAL_INVESTIGATOR

Hôpital NOVO

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHRD1715

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.